The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Mediastinal lipomatosis
Publications
Images in clinical medicine. Asymptomatic mediastinal lipomatosis.
The New England journal of medicine 2010 Sep 23;363;1265 — 2010 Sep 23 — 1265
Steroid-induced mediastinal lipomatosis with radiographic features of pericardial effusion.
The American journal of emergency medicine 2000 May;18;346-8 — 2000 May — 346-8
[Lipomatosis induced by corticosteroid therapy].
La Revue de medecine interne 1997;18;396-401 — 1997 — 396-401
Mediastinal lipomatosis secondary to steroid therapy.
The American journal of roentgenology, radium therapy, and nuclear medicine 1966 Oct;98;461-4 — 1966 Oct — 461-4
Widening of the mediastinum resulting from fat accumulation.
Radiology 1970 Sep;96;497-500 — 1970 Sep — 497-500